Genomic Medicine Sweden
Genomic Medicine Sweden, GMS, is paving the way for improved diagnostics, care and treatment.
Genomic Medicine Sweden and Danish National Genome Center in partnership to advance precision medicine
Genomic Medicine Sweden and the Danish National Genome Center has signed an agreement with the aim to advance genomics and precision medicine and its implementation in healthcare. The joint partnership will focus on the development and implementation of innovative...
Sequencing of 7,000 genomes in Swedish clinical practice in 2021 for better diagnosis and treatment
In 2021, analyzes were performed of 5,000 samples with whole genome sequencing and almost 2,000 samples with whole exome sequencing in clinical routine in Sweden. The majority of these analyzes were performed for the diagnosis of patients with rare diseases. In...
The legal room for sharing genetic data for the purpose of providing care for others is limited
There are currently no legal opportunities for the healthcare regions to, on a large scale, access the genetic data of patients in other regions for the purpose of providing better and more equal care for patients all across Sweden. This is shown in a new report by...
Sweden’s ambitious national collaboration for genomic medicine
Our strategic mission is to foster collaboration between healthcare providers, academia, patient organizations and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
A close collaboration between healthcare and academia is central in introducing new forms of diagnostics as the basis for an individualized choice of treatment.
Patients & next of kin
Participation and knowledge from patients and next of kin representatives is crucial for GMS to be able to introduce precision medicine in health care based on the individual’s needs.
Through an active collaboration with industry, GMS will develop and provide tomorrow´s solutions for the diagnostics and treatment of various diseases.
GMS forms a strong basis for researchers to better understand why disease arises and how new forms of treatment can be developed.
JIM Symposium: Cutting-Edge Implementation of Precision Medicine in Europe
22-23 September, 2022 in Stockholm
This symposium focuses on how precision medicine will change and improve diagnostics, treatment and prevention, as well as the potential for research and innovation within the precision medicine framework.
Seven regional centers are the GMS engine
GMS is comprised of seven regional Genomic Medicine Centers (GMC). These joint centers act as the primary point of contact for sequencing patient samples within healthcare, thereby creating an integrated platform for both healthcare delivery and advanced medical research. Each GMC is a collaboration between a region with university hospital care, a university with a faculty of medicine, and SciLifeLab.